1. The Relationship between Metal Exposure and Chronic Obstructive Pulmonary Disease in the General US Population: NHANES 2015–2016
   Qiaoyuan Fei et al, 2022, International Journal of Environmental Research and Public Health CrossRef
2. Lysyl oxidase‐like 2 inhibitor rescues D‐galactose‐induced skeletal muscle fibrosis
   Yongxin Wu et al, 2022, Aging Cell CrossRef
3. Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway
   Rong Zeng et al, 2024, Respiratory Research CrossRef
4. Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3
   Alison D. Findlay et al, 2019, Journal of Medicinal Chemistry CrossRef
5. Serum Copper-to-Zinc Ratio and Risk of Chronic Obstructive Pulmonary Disease: A Cohort Study
   Setor K. Kunutsor et al, 2023, Lung CrossRef
6. Protective effect of melatonin entrapped PLGA nanoparticles on radiation-induced lung injury through the miR-21/TGF-β1/Smad3 pathway
   Shuang Wang et al, 2021, International Journal of Pharmaceutics CrossRef
7. Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
   Tianyi Liu et al, 2019, Frontiers in Cell and Developmental Biology CrossRef
8. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
   Yingbiao Wu et al, 2022, Cerebrovascular Diseases CrossRef
9. SPECT Imaging of Lysyl Oxidase-like 2 in a Model of Idiopathic Pulmonary Fibrosis
   Romane Vizier et al, 2023, Molecular Pharmaceutics CrossRef
10. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge
    Wei Song et al, 2024, Frontiers in Physiology CrossRef